Skip to main content
. 2021 Nov 30;15(6):1402–1412. doi: 10.1007/s12072-021-10250-2

Fig. 1.

Fig. 1

Workflow and schematic of study design. a The Workflow of HBV-TCR-T-cell therapy. PBMCs are harvested, expanded, redirected short-lived mRNA HBV-Env-specific-TCR by electroporation and transferred back into the same patient. b The clinical protocol showing the overall study design included the infusion cycle, infusion dose and the main outcomes